These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 31689460)

  • 1. Transdermal finasteride delivery via powder-carrying microneedles with a diffusion enhancer to treat androgenetic alopecia.
    Kim S; Eum J; Yang H; Jung H
    J Control Release; 2019 Dec; 316():1-11. PubMed ID: 31689460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Systematic Review of Topical Finasteride in the Treatment of Androgenetic Alopecia in Men and Women.
    Lee SW; Juhasz M; Mobasher P; Ekelem C; Mesinkovska NA
    J Drugs Dermatol; 2018 Apr; 17(4):457-463. PubMed ID: 29601622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Finasteride Topical Delivery Systems for Androgenetic Alopecia.
    Khan MZU; Khan SA; Ubaid M; Shah A; Kousar R; Murtaza G
    Curr Drug Deliv; 2018; 15(8):1100-1111. PubMed ID: 29366416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of Finasteride-Loaded Nanoparticles for Potential Treatment of Alopecia.
    Roque LV; Dias IS; Cruz N; Rebelo A; Roberto A; Rijo P; Reis CP
    Skin Pharmacol Physiol; 2017; 30(4):197-204. PubMed ID: 28689207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controversies in the treatment of androgenetic alopecia: The history of finasteride.
    Andy G; John M; Mirna S; Rachita D; Michael K; Maja K; Aseem S; Zeljana B
    Dermatol Ther; 2019 Mar; 32(2):e12647. PubMed ID: 30253001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical formulations containing finasteride. Part I: in vitro permeation/penetration study and in vivo pharmacokinetics in hairless rat.
    Monti D; Tampucci S; Burgalassi S; Chetoni P; Lenzi C; Pirone A; Mailland F
    J Pharm Sci; 2014 Aug; 103(8):2307-14. PubMed ID: 24942358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study.
    Shanshanwal SJ; Dhurat RS
    Indian J Dermatol Venereol Leprol; 2017; 83(1):47-54. PubMed ID: 27549867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable powder-carrying microneedles for transdermal delivery of high-dose insulin with enhanced activity.
    Kim S; Yang H; Eum J; Ma Y; Fakhraei Lahiji S; Jung H
    Biomaterials; 2020 Feb; 232():119733. PubMed ID: 31901501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and in vitro evaluation of finasteride-loaded liquid crystalline nanoparticles for topical delivery.
    Madheswaran T; Baskaran R; Thapa RK; Rhyu JY; Choi HY; Kim JO; Yong CS; Yoo BK
    AAPS PharmSciTech; 2013 Mar; 14(1):45-52. PubMed ID: 23207960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of finasteride polymer microspheres for systemic application in androgenic alopecia.
    Kim JH; Na J; Bak DH; Lee BC; Lee E; Choi MJ; Ryu CH; Lee S; Mun SK; Park BC; Kim BJ; Lee HS
    Int J Mol Med; 2019 Jun; 43(6):2409-2419. PubMed ID: 30942390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-therapies in androgenetic alopecia: review and clinical experiences.
    Rossi A; Anzalone A; Fortuna MC; Caro G; Garelli V; Pranteda G; Carlesimo M
    Dermatol Ther; 2016 Nov; 29(6):424-432. PubMed ID: 27424565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date.
    Iamsumang W; Leerunyakul K; Suchonwanit P
    Drug Des Devel Ther; 2020; 14():951-959. PubMed ID: 32184564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy with finasteride and low-dose dutasteride in the treatment of androgenetic alopecia.
    Boyapati A; Sinclair R
    Australas J Dermatol; 2013 Feb; 54(1):49-51. PubMed ID: 22686691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporation of Finasteride-Loaded Microspheres into Personalized Microneedle for Sustained Transdermal Delivery.
    Luo W; Zhang X; Chu Y; Chen T; Sun H; Liu J; Zhang G; Fan L; Xu H; Zhang Y; Yang M
    Langmuir; 2024 May; 40(20):10551-10560. PubMed ID: 38710593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced Follicular Delivery of Finasteride to Human Scalp Skin Using Heat and Chemical Penetration Enhancers.
    Farah HA; Brown MB; McAuley WJ
    Pharm Res; 2020 May; 37(6):112. PubMed ID: 32476090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
    Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in microneedles research based on promoting hair regrowth.
    Zhou Y; Jia L; Zhou D; Chen G; Fu Q; Li N
    J Control Release; 2023 Jan; 353():965-974. PubMed ID: 36549392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of liposomal systems of finasteride for topical applications: design, characterization, and in vitro evaluation.
    Kumar R; Singh B; Bakshi G; Katare OP
    Pharm Dev Technol; 2007; 12(6):591-601. PubMed ID: 18161632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Observing the clinical efficacy of combined serum microneedle therapy for moderate to severe androgenetic alopecia in scalp repair.
    Zhang F; Jia S; Ye B; Li F; Zhang J; Jin Q; Li M
    Skin Res Technol; 2024 Feb; 30(2):e13612. PubMed ID: 38348763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid nanoparticles for topical and transdermal application for alopecia treatment: development, physicochemical characterization, and in vitro release and penetration studies.
    Gomes MJ; Martins S; Ferreira D; Segundo MA; Reis S
    Int J Nanomedicine; 2014; 9():1231-42. PubMed ID: 24634584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.